MyAverix Finance
NS · Pharmaceuticals
Biocon Ltd (BIOCON)
Pharmaceuticals & Biotechnology
Biocon Ltd (BIOCON) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $686.37B, P/E ratio is 1,841.09, net margin is 10.4%, dividend yield is 0.12%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BIOCON
Biocon Ltd (BIOCON) — FAQ
What is Biocon Ltd's market cap?
Biocon Ltd (BIOCON) has a reported market cap of $686.37B (data as of 2026-07-10).
What is BIOCON's P/E ratio?
The price-to-earnings (P/E) ratio for Biocon Ltd (BIOCON) is 1,841.09 (data as of 2026-07-10).
Does Biocon Ltd pay a dividend?
Biocon Ltd (BIOCON) shows a reported dividend yield of 0.12%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Biocon Ltd in?
Biocon Ltd (BIOCON) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is BIOCON listed on?
BIOCON is listed on NS.
What is Biocon Ltd's net margin?
Biocon Ltd (BIOCON) reports a net margin of 10.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.